Tags: Case, Legal Case, Supreme Court Of The United States Case, Unit Of Work.

United States v. Glaxo Group Ltd. 410 U.S. 52 (1973) is a decision of the United States Supreme Court in which the Court held that (1) when a patent is directly involved in an antitrust violation the Government may challenge the validity of the patent; and (2) ordinarily in patent-antitrust cases “[m]andatory selling on specified terms and compulsory patent licensing at reasonable charges are recognized antitrust remedies.”

Loading...

This page contains content from the copyrighted Wikipedia article "United States v. Glaxo Group Ltd."; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.